Ocitinib mostly refers to ocitinib mesylate tablets, and patients may experience adverse reactions such as eyelid swelling after consuming ocitinib mesylate tablets as prescribed by their doctor.
Ocitinib mesylate tablets are suitable for the treatment of locally advanced or metastatic non-small cell lung cancer, but some patients may experience adverse reactions such as keratitis and swelling of upper and lower eyelids after consuming ocitinib mesylate tablets, but generally, after stopping the drug, the swelling of the eyelids of the patients can subside and return to normal.
Patients may also experience adverse reactions such as stomatitis, diarrhea, interstitial lung disease, rash, dry skin, onychomycosis, itchy skin, and other adverse reactions after using oxitinib mesylate tablets. It is contraindicated for people who are allergic to the ingredients of Ocitinib Mesylate Tablets, pregnant women, lactating women and other people.
Patients are advised to use Ocitinib Mesylate Tablets under the guidance of a doctor, do not use it without authorization to avoid adverse reactions.